Steroids and immunoglobulins for severe sudden heart inflammation
Part of Heart & circulation clinical trials.
This trial tests if high-dose steroids and/or immunoglobulins (antibody treatments) help people with sudden, severe heart inflammation (fulminant myocarditis) that causes shock or dangerous heart rhythms. The goal is to see which treatment or combination reduces heart damage and improves recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a sudden, severe heart inflammation (fulminant myocarditis) that started within the last month.
- You needed medicines or a temporary pump to support your heart within the first 72 hours.
- You are 15 years old or older.
- You do not have another known heart condition like blocked arteries or a pre-existing weak heart.
- You are not pregnant, breastfeeding, or within 6 months of giving birth.
- You do not have a serious active infection or known allergy to steroids or immunoglobulins.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether steroid medicine helps people hospitalized with suspected acute myocarditis (inflammation of the heart). Participants are randomly assigned to receive steroids or a placebo, and the trial looks at outcomes after the acute episode starts.
This trial tests if non-steroidal anti-inflammatory drugs (NSAIDs), like ibuprofen, help people with acute myocarditis (inflammation of the heart muscle) who are hospitalized but have normal heart function. It aims to see if these drugs can reduce inflammation and improve recovery.
This study is creating a national registry to learn more about inflammatory myocardial disease (inflammation of the heart muscle). If you have symptoms like chest pain, shortness of breath, palpitations, or certain test results, you may be eligible to join and help advance research.
This Phase 3 trial tests abatacept to treat myocarditis (inflammation of the heart muscle) caused by immune checkpoint cancer medicines. It may help patients recover faster and safely manage this serious side effect while they are in the hospital.
This trial uses an imaging technique called NH IMR Angio to look at the tiny blood vessels in the heart of patients hospitalized with acute myocarditis (inflammation of the heart muscle). The goal is to see if problems with these small vessels affect recovery over the next year.
This study looks at people hospitalized for a heart muscle inflammation called myocarditis. It aims to better understand the risk of heart rhythm problems, which could help guide future care.
Hear when a new Myocarditis Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.